These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30124106)

  • 1. Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study.
    Skjerbæk AG; Boesen F; Petersen T; Rasmussen PV; Stenager E; Nørgaard M; Feys P; Kjeldgaard-Jørgensen ML; Hvid LG; Dalgas U
    Mult Scler; 2019 Oct; 25(12):1653-1660. PubMed ID: 30124106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported maximum walking distance in persons with MS may affect the EDSS.
    Berger W; Payne MWC; Morrow SA
    J Neurol Sci; 2017 Aug; 379():77-80. PubMed ID: 28716284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
    J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Expanded Disability Status Scale scoring in patients with multiple sclerosis].
    Füvesi J
    Ideggyogy Sz; 2019 Sep; 72(9-10):317-323. PubMed ID: 31625698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fatigability on Expanded Disability Status Scale components in multiple sclerosis.
    Dujmović I; Demetz S; Millonig A; Deisenhammer F
    Srp Arh Celok Lek; 2016; 144(5-6):262-5. PubMed ID: 29648741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking function in clinical monitoring of multiple sclerosis by telemedicine.
    Sola-Valls N; Blanco Y; Sepúlveda M; Llufriu S; Martínez-Lapiscina EH; La Puma D; Graus F; Villoslada P; Saiz A
    J Neurol; 2015 Jul; 262(7):1706-13. PubMed ID: 25957639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test.
    Leone C; Severijns D; Doležalová V; Baert I; Dalgas U; Romberg A; Bethoux F; Gebara B; Santoyo Medina C; Maamâgi H; Rasova K; Maertens de Noordhout B; Knuts K; Skjerbaek A; Jensen E; Wagner JM; Feys P
    Neurorehabil Neural Repair; 2016 May; 30(4):373-83. PubMed ID: 26216790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
    Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter.
    Albrecht H; Wötzel C; Erasmus LP; Kleinpeter M; König N; Pöllmann W
    Mult Scler; 2001 Apr; 7(2):105-9. PubMed ID: 11424630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
    Kahraman T; Savci S; Coskuner Poyraz E; Ozakbas S; Idiman E
    NeuroRehabilitation; 2016; 38(1):7-14. PubMed ID: 26889793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
    Gijbels D; Dalgas U; Romberg A; de Groot V; Bethoux F; Vaney C; Gebara B; Medina CS; Maamâgi H; Rasova K; de Noordhout BM; Knuts K; Feys P
    Mult Scler; 2012 Mar; 18(3):364-71. PubMed ID: 21952098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
    de David AC; Sasaki JE; Ramari C; Tauil CB; Moraes AG; Martins F; von Glehn F; Motl RW
    Mult Scler Relat Disord; 2019 May; 30():208-214. PubMed ID: 30818129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
    Neven A; Janssens D; Alders G; Wets G; Van Wijmeersch B; Feys P
    Disabil Rehabil; 2013 Sep; 35(20):1718-25. PubMed ID: 23343357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic-assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis.
    Vaney C; Gattlen B; Lugon-Moulin V; Meichtry A; Hausammann R; Foinant D; Anchisi-Bellwald AM; Palaci C; Hilfiker R
    Neurorehabil Neural Repair; 2012; 26(3):212-21. PubMed ID: 22140197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multidimensional assessment of multiple sclerosis: relationships between disability domains.
    Provinciali L; Ceravolo MG; Bartolini M; Logullo F; Danni M
    Acta Neurol Scand; 1999 Sep; 100(3):156-62. PubMed ID: 10478578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.